Revolutionary innovation from InQpharm allows consumers to reduce fat absorption whilst increasing nutritional intake

InQpharm launches Liposinol™ with Vitamins to extend its range of leading weight management products. A clinically-proven organic fat-binder for general weight management, treatment and prevention of obesity, Liposinol™ with Vitamins provides the first medical device fat-binder with added vitamins A, D and E. It nutritionally replenishes the body whilst binding up to 26.6% of dietary fats, thus aiding the prevention and treatment of obesity.

Liposinol™, enriched with essential fat-soluble vitamins A, D and E, provides a revolutionary double-action tablet that addresses weight management issues, while replenishing the body by delivering 100% of the recommended daily intake of vitamins A (800mcg), D (5mcg) and E (10mg). 

This fat-binding action is made possible by the release of Litramine. A patented fibre complex derived from 100% organic dehydrated cactus leaves, Litramine is nutritious, rich in fibre and binds dietary fats naturally.

Vitamins A, D and E are key micronutrients which the body requires on a daily basis to help it function properly. A small, but essential, intake of these vitamins is vital to help stay in good health during weight management, supporting an effective metabolism that will encourage the body to convert food into energy.

Large quantities of essential nutrients such as vitamin E are commonly found in calorific foods – the foods that dieters tend to avoid.  At the same time, those on weight management programmes often increase their physical activity, thus amplifying their utilisation of these vital nutrients. 

Traditionally, fat-binders and blockers have shown the risk of affecting fat-soluble vitamin absorption. This is especially true when they are taken together with a diet rich in vitamins that rely on fat for absorption. By applying Circadian technology, InQpharm ensures that this new revolutionary product releases the vitamins when the fat-binding phase is complete, thus eliminating any chance of the added fat-soluble vitamins becoming bound.

Launched in four markets – Germany, UK, Austria and France – Liposinol™ with Vitamins is certified as a Class IIa medical device product due to its ability to bind fats without any pharmacological action on the body. Its safety and efficacy are assessed under Medical Device Directive 93/42/EEC and it has shown no known side effects.

Vivian Cheh, Marketing Director, comments: “We pioneered obtaining a medical device licence for our first product Liposinol™. This certification enabled us to make product claims in the EU and for Liposinol™ to become the best-selling fat-binding product in many European countries.

We are dedicated to continuing to improve on the quality and promise we deliver to our consumers, and this conviction has led us to the launch of Liposinol™ with Vitamins.  We are delighted to be able to supply our customers with the benefits of our excellent product, plus the extra nutritional advantage. We are equally excited about our dynamic product development plan, which includes the introduction of a unique natural carbohydrate blocker, and an innovative appetite management product later this year.”

For further information please email: enquiries@inqpharm.com